SCHEMBL16615317

SCHEMBL16615317

O=C(Nc1ccc(N2CCOCC2)cc1)c1cc2c([nH]1)NCCN2Cc1cc(Cl)ccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
HTT P42858 4/20 0.44
LMNA P02545 3/20 0.44
MAPK1 P28482 1/20 0.44
MCL1 Q07820 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HTR1B P28222 2/20 0.42
PDE7A Q13946 1/20 0.42
RAB9A P51151 2/20 0.41
POLB P06746 2/20 0.41
DGAT1 O75907 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.41
F10 P00742 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17969743 0.89 MAPT (0.45) MAPTSMN1; SMN2KMT2AMEN1HTT
SCHEMBL16615214 0.88 RAB9A (0.41) MAPTSMN1; SMN2KMT2AMEN1LMNA
SCHEMBL17918706 0.82 MAPT (0.44) MAPTSMN1; SMN2KMT2AMEN1HTT
SCHEMBL16615102 0.80 MAPT (0.44) MAPTSMN1; SMN2KMT2AMEN1HTT
SCHEMBL17969809 0.79 MAPT (0.42) MAPTSMN1; SMN2KMT2AMEN1HTT
SCHEMBL17969746 0.78 MAPT (0.43) MAPTSMN1; SMN2KMT2AMEN1HTT
SCHEMBL16615281 0.76 SMN1; SMN2 (0.41) MAPTSMN1; SMN2KMT2AMEN1HTT
SCHEMBL18106077 0.76 KMT2A (0.40) MAPTSMN1; SMN2KMT2AMEN1HTT
SCHEMBL18106054 0.75 ALK (0.53) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL20859416 0.74 MAPT (0.42) MAPTSMN1; SMN2KMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050884-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES Limited Liability Company "National Pharmaceutical (RU) 2016-08-03 EP disclosed
WO-2015047133-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" 2015-04-02 WO disclosed